This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Delivered as Hybrid Event from 15-18 November 2022
Live In-Person Conference Delivered 15-18 NovemberAustria Center Vienna

Keith Jarvis
Senior Director, Process Chemistry at Editas Medicine

Profile

Keith Jarvis is currently the Senior Director of Process Chemistry at Editas Medicine. His team is responsible for small scale guide RNA production to support research, the development of novel chemical modifications to guide RNA to enhance delivery, process development and optimization of lead guides once a development candidate is declared and large scale guide RNA manufacturing. He received his Bachelor of Science degree in Chemistry from the University of North Carolina at Chapel Hill and his Master of Science Degree from the University of Colorado at Boulder. He has also led other oligonucleotide related process development and production groups at several other biotechnology companies including Ribozyme Pharmaceuticals, Sirna Therapeutics, Merck Research Laboratories and miRagen Therapeutics.

Agenda Sessions

  • IND-enabling Small Scale Guide RNA Production Under GMP for CRISPR Based Cell Therapies

    08:45

Speakers at this event